|
CRAMP1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.89860000000031E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.16770000014155E-07 |
| Normal-vs-Stage2 |
1.176610E-01 |
| Normal-vs-Stage3 |
6.716100E-02 |
| Normal-vs-Stage4 |
2.244400E-01 |
| Stage1-vs-Stage2 |
9.494100E-02 |
| Stage1-vs-Stage3 |
1.075760E-02 |
| Stage1-vs-Stage4 |
8.997600E-03 |
| Stage2-vs-Stage3 |
8.443000E-01 |
| Stage2-vs-Stage4 |
6.120000E-01 |
| Stage3-vs-Stage4 |
6.894000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.845600E-04 |
| Normal-vs-AfricanAmerican |
3.812300E-04 |
| Normal-vs-Asian |
3.503600E-02 |
| Caucasian-vs-AfricanAmerican |
3.672000E-02 |
| Caucasian-vs-Asian |
8.965600E-02 |
| AfricanAmerican-vs-Asian |
4.528000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.264100E-03 |
| Normal-vs-Female |
4.29879999996885E-06 |
| Male-vs-Female |
5.573700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.669610E-01 |
| Normal-vs-Age(41-60Yrs) |
1.85269999997129E-06 |
| Normal-vs-Age(61-80Yrs) |
9.160500E-03 |
| Normal-vs-Age(81-100Yrs) |
5.800800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.456800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.079200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.208400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.212300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.173400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.374200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.29760000522339E-08 |
| Normal-vs-Grade 2 |
4.12120000004013E-06 |
| Normal-vs-Grade 3 |
7.516600E-03 |
| Normal-vs-Grade 4 |
6.518000E-01 |
| Grade 1-vs-Grade 2 |
1.918270E-02 |
| Grade 1-vs-Grade 3 |
1.624890E-04 |
| Grade 1-vs-Grade 4 |
1.390850E-04 |
| Grade 2-vs-Grade 3 |
2.452300E-02 |
| Grade 2-vs-Grade 4 |
4.240800E-03 |
| Grade 3-vs-Grade 4 |
1.075950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.56110000000465E-05 |
| Normal-vs-ccB subtype |
5.078200E-03 |
| ccA subtype-vs-ccB subtype |
2.160800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.972300E-04 |
| Normal-vs-N1 |
7.770000E-01 |
| N0-vs-N1 |
9.669600E-02 |
|
|
